Body

Important new model shows how proteins find the right DNA sequences

Researchers at Uppsala University and Harvard University have collaboratively developed a new theoretical model to explain how proteins can rapidly find specific DNA sequences, even though there are many obstacles in the way on the chromosomes. The findings are being published today in the scientific journal Nature Physics.

Odds are, seedings don't matter after Sweet 16, University of Illinois professor says

CHAMPAIGN, Ill. — For budding "bracketologists" busily weighing picks for their annual March Madness office pool, a University of Illinois professor has some advice on how to pick winners: In the later rounds of the tournament, ignore a team's seeding, which is a statistically insignificant predictor of a team's chances of winning.

Hospital infection control strategies for antibiotic-resistant organisms

Source:

Early results favorable for 5-day radiation treatment of early stage prostate cancer

Preliminary results show that a shortened course of radiation therapy for prostate cancer called stereotactic body radiation therapy (SBRT) provides good PSA response for early-stage prostate cancer and has the same side effects as other treatments, according to a March 15 study in the International Journal of Radiation Oncology*Biology*Physics, the official journal of the American Society for Radiation Oncology (ASTRO). Study authors caution that further follow-up will be necessary to establish that SBRT is as effective in the long term as other proven treatments.

Selected men with low-risk prostate cancer have good clinical outcomes without immediate treatment

A multi-center study of prostate cancer patients appearing in today's Journal of Urology recommends that for some men diagnosed with low-risk prostate cancer, opting not to initially receive treatment can be safe if they are closely monitored.

No hiding place for infecting bacteria

Scientists in Colorado have discovered a new approach to prevent bacterial infections from taking hold. Writing in the Journal of Medical Microbiology, Dr Quinn Parks and colleagues describe how they used enzymes against products of the body's own defence cells to prevent Pseudomonas aeruginosa bacteria from building a protective biofilm which enables them to avoid both the body's immune mechanisms and antibiotics.

Cellular discovery may lead to targeted treatment for rare form of anemia

CINCINNATI—University of Cincinnati (UC) researchers have identified the specific biological mechanisms believed to lead to a rare and incurable blood disease known as Diamond Blackfan anemia (DBA). Scientists say with further investigation, their discoveries could result in drastic changes to current thinking about treatment for this disease and may lead to promising new drug therapies.

Genetic abnormality may increase risk of blood disorders

NEW YORK, March 15, 2009 – Researchers at Memorial Sloan-Kettering Cancer Center (MSKCC) have shown for the first time that a tendency to develop some blood disorders may be inherited. Their research, published online today in Nature Genetics, identifies a common genetic sequence abnormality that enhances the likelihood of acquiring a mutation in a gene linked to certain blood diseases.

A sticky business -- how cancer cells become more 'gloopy' as they die

The viscosity, or 'gloopiness', of different parts of cancer cells increases dramatically when they are blasted with light-activated cancer drugs, according to new images that provide fundamental insights into how cancer cells die, published in Nature Chemistry today (15 March).

The images reveal the physical changes that occur inside cancer cells whilst they are dying as a result of Photodynamic Therapy (PDT). This cancer treatment uses light to activate a drug that creates a short-lived toxic type of oxygen, called singlet oxygen, which kills cancerous cells.

Blocking protein may help ease painful nerve condition

March 13, 2009 — Scientists have identified the first gene that pulls the plug on ailing nerve cell branches from within the nerve cell, possibly helping to trigger the painful condition known as neuropathy.

The condition is a side effect of some forms of chemotherapy and can also afflict patients with cancer, diabetes, kidney failure, viral infections, neurodegenerative disorders and other ailments.

Studies show children can complete treatment for peanut allergies and achieve long-term tolerance

DURHAM, NC -- A carefully administered daily dose of peanuts has been so successful as a therapy for peanut allergies that a select group of children is now off treatment and eating peanuts daily, report doctors at Duke University Medical Center and Arkansas Children's Hospital.

"It appears these children have lost their allergies," says Wesley Burks, MD, Chief of the Division of Pediatric Allergy and Immunology at Duke. "This gives other parents and children hope that we'll soon have a safe, effective treatment that will halt allergies to certain foods."

First successful transvaginal nephrectomy performed using advanced surgical concepts' tri-port

CARACAS, VENEZUELA – March 13, 2009 – Dr. Rene Sotelo is pleased to announce the world's first successful live human transvaginal nephrectomy using the Tri-port multi-channel port supplied by Advanced Surgical Concepts Ltd. This ground breaking surgery was performed by Dr. Sotelo and his team at the Instituto Medico La Floresta in Caracas, Venezuela on March 7, 2009.

Traffic exposure may have a triggering effect on heart attack

People who have had a heart attack are likely to report having been in traffic shortly before their symptoms began, researchers reported at the American Heart Association's 49th Annual Conference on Cardiovascular Disease Epidemiology and Prevention.

Einstein researchers develop novel antibiotics that don't trigger resistance

March 13, 2009 – (BRONX, NY) – Bacterial resistance to antibiotics is one of medicine's most vexing challenges. In a study described in Nature Chemical Biology, researchers from Albert Einstein College of Medicine of Yeshiva University are developing a new generation of antibiotic compounds that do not provoke bacterial resistance. The compounds work against two notorious microbes: Vibrio cholerae, which causes cholera; and E. coli 0157:H7, the food contaminant that each year in the U.S. causes approximately 110,000 illnesses and 50 deaths.

New method for detecting explosives

COLLEGE PARK, MD (Mar 12, 2009) -- A group of researchers in Tennessee and Denmark has discovered a way to sensitively detect explosives based on the physical properties of their vapors. Their technology, which is currently being developed into prototype devices for field testing, is described in the latest issue of the journal Review of Scientific Instruments, which is published by the American Institute of Physics (AIP).